Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

256.63 +0.34 (+0.13%)
Streaming Delayed Price Updated: 1:30 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
ResMed (NYSE:RMD) Surprises With Q2 Sales
Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share was 3% above... 
Via StockStory
News headline image
Resmed Inc. (NYSE:RMD) Beats Q4 2025 Revenue and EPS Estimates Despite Muted Market Reaction ↗
Resmed Inc. (NYSE:RMD) beats Q4 2025 revenue and EPS estimates, reporting $1.35B and $2.55, respectively. Stock dips slightly amid muted market reaction despite strong growth and dividend hike. 
Via Chartmill
News headline image
Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025
From Resmed, Inc.
Via GlobeNewswire
News headline image
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday? ↗
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp. 
Via Benzinga
Topics Economy
News headline image
Earnings Scheduled For July 31, 2025 ↗
 
Via Benzinga
News headline image
ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Analyst Expectations For ResMed's Future ↗
 
Via Benzinga
News headline image
2 Reasons to Watch RMD and 1 to Stay Cautious
ResMed trades at $254.11 per share and has stayed right on track with the overall market, gaining 8.9% over the last six months. At the same time, the S&P 500 has returned 5.4%. 
Via StockStory
Topics Government Stocks
News headline image
Motley Fool Co-Founder David Gardner Reviews Stock Picks ↗
Via The Motley Fool
News headline image
2 S&P 500 Stocks with Promising Prospects and 1 to Steer Clear Of
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Economy Stocks
News headline image
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
From Resmed, Inc.
Via GlobeNewswire
News headline image
RESMED INC (NYSE:RMD) – A Strong Candidate for Quality Investors ↗
RESMED INC (NYSE:RMD) is a high-quality stock with strong revenue growth, exceptional ROIC, and solid cash flow, making it a standout pick for long-term investors. 
Via Chartmill
News headline image
2 Cash-Producing Stocks to Consider Right Now and 1 to Ignore
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
Looking Back on a Motley Fool Career ↗
Via The Motley Fool
News headline image
ResMed: A Mixed Bag for Investors Amid Rising Competition ↗
Via The Motley Fool
News headline image
RESMED INC (NYSE:RMD) – A Strong Contender for Quality Investors ↗
RESMED INC (NYSE:RMD) is a high-quality stock with strong profitability, low debt, and consistent growth, making it a candidate for long-term investors. 
Via Chartmill
News headline image
2 Large-Cap Stocks with Competitive Advantages and 1 to Approach with Caution
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
Topics Fraud
News headline image
3 Cash-Heavy Stocks with Competitive Advantages
Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. Without interest payments being less of a worry, these businesses can invest... 
Via StockStory
News headline image
2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
1 Surging Stock with Exciting Potential and 2 to Avoid
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage... 
Via StockStory
News headline image
ResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From Investigational Sleep Apnea Drug: Retail’s Unmoved ↗
RBC Capital noted that ResMed now has “a number of competitive threats on the horizon." 
Via Stocktwits
Topics Government
News headline image
What's going on in today's pre-market session: S&P500 movers ↗
Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session. 
Via Chartmill
News headline image
1 Unpopular Stock that Should Get More Attention and 2 to Brush Off
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
News headline image
RESMED INC (NYSE:RMD) – A Quality Stock with Strong Fundamentals ↗
RESMED INC (NYSE:RMD) is a high-quality stock with strong revenue growth, exceptional profitability, and a solid balance sheet, making it a standout pick for long-term investors. 
Via Chartmill
News headline image
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗
Via The Motley Fool
Topics Retirement
News headline image
Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
From Resmed, Inc.
Via GlobeNewswire
News headline image
Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ResMed (NYSE:RMD) and the best and worst... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Profitable Stocks to Consider Right Now
Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion. The best of these businesses balance profitability with reinvestment, setting... 
Via StockStory
News headline image
Resmed Acquires VirtuOx
Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers 
From Resmed, Inc.
Via GlobeNewswire
News headline image
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Monday. Stay informed about the latest market trends. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.